Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06351657

Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression

Sponsor: Medical University of Vienna

View on ClinicalTrials.gov

Summary

The goal of this prospective, multinational, multicenter observational study is to assess and predict progression in non-foveal, non-vision compromising atrophic AMD on an individual-based level over two years. The main objectives of this study are: * Assess the individual progression rate of a patient in non-foveal, non-vision compromising atrophic AMD and assess personalized risk of progression based on imaging. * Identify and quantify focal and global alterations in the retina in regard to disease progression. * Evaluate the monitoring of AMD progression using approved AI algorithms. All patients will be followed for 24 months with 6 month intervals to assess clinical changes. Monitoring of disease progression will be performed using the following routine in-vivo imaging procedures: * Scanning Laser Fundus Photography * Color Fundus Photography (CFP) * Optical Coherence Tomography (OCT) * Optical Coherence Tomography Angiography (OCTA) Patients will be asked for their medical history. Standard ophthalmic examination, as well as a questionnaire on visual function will be carried out. No intervention will be performed during the study since no treatment is yet available within Europe. As soon as treatment is approved in the EU, patients in this cohort might receive treatment according to availability in their respective country and standard of care. If treatment will be performed, it will be as standard of care outside the study according to each country's standard of care and by EMA label.

Official title: Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression in a Prospective, Multinational, Multicenter Observational Study

Key Details

Gender

All

Age Range

55 Years - 99 Years

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2025-04-11

Completion Date

2027-07

Last Updated

2025-05-15

Healthy Volunteers

No

Locations (7)

Medical University of Vienna

Vienna, Austria

CHU Dijon

Dijon, France

University Medical Center Ljubljana

Ljubljana, Slovenia

Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomed

Barcelona, Spain

Vista Klinik Binningen

Binningen, Switzerland

University of Zürich

Zurich, Switzerland

Queen's Unviversity Belfast

Belfast, United Kingdom